ALL
Company Details
Linkedin ID:
alkem-laboratories-ltd
Website:
Employees number:
15,251
Number of followers:
647,457
NAICS:
3254
Industry Type:
Homepage:
alkemlabs.com
IP Addresses:
0
Company ID:
ALK_3196569
Scan Status:
In-progress
Alkem Laboratories Ltd. Company CyberSecurity Posture
alkemlabs.com
A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient, like a spark that could ignite a thousand more ideas. And it did! Looking back at our 4 decade, illustrious journey, that one small idea has Not only triggered us to become one of India’s largest generic and specialty pharmaceutical company but also, create a foothold in over 50 countries 32% of our revenue is generated via offshore sales. As well as we have consistently been ranked amongst the top ten pharmaceutical companies in India. Our portfolio includes illustrious brands like Clavam, Pan, Pan-D and Taxim-O, which feature amongst top 50 pharmaceutical brands in India. For over a decade, our dominance in anti-infective segment has remained unchallenged. We have 21 manufacturing facilities at multiple locations in India and the United States of America. Our upper-crest facilities are inspected and audited as per cGMP guidelines as laid down by leading regulatory authorities such as USFDA, MHRA - UK, SAHPRA-South Africa, TGA - Australia, ANVISA - Brazil, WHO - Geneva, TPD - Health Canada, PPB - Kenya, NDA - Uganda, MOH - Sudan, INVIMA - Colombia, TFDA - Tanzania, Zimbabwe, BfArM-Germany & Other Africa, Asian & CIS Countries. Another feather in our cap was added on December 23rd, 2015, when, Alkem completed it's Initial Public Offering (IPO) and was listed on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited. Although passion is the fuel that keeps ideas alive, innovation is the catalyst that gives it flight! With over 500 scientists working in 5 global R&D centers, we are empowering innovations that align with our philosophy of ‘Extended Lifecare Beyond Boundaries’.
Alkem Laboratories Ltd. A.I CyberSecurity Scoring
ALL Risk Score (AI oriented)Between 750 and 799
ALL
Updated:
- Powered by our proprietary A.I cyber incident model
- Insurance preferes TPRM score to calculate premium
ALL Global Score (TPRM)XXXX
ALL
- Instant access to detailed risk factors
- Benchmark vs. industry & size peers
- Vulnerabilities
- Findings
ALL Company CyberSecurity News & History
Past Incidents
0
Attack Types
0
No data available
ALL Company Scoring based on AI Models
Cyber Incidents Likelihood 3 - 6 - 9 months
A.I Risk Score Likelihood 3 - 6 - 9 months
Underwriter Stats for ALL
Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)
No incidents recorded for Alkem Laboratories Ltd. in 2025.
Incidents vs All-Companies Average (This Year)
No incidents recorded for Alkem Laboratories Ltd. in 2025.
Incident Types ALL vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Alkem Laboratories Ltd. in 2025.
Incident History — ALL (X = Date, Y = Severity)
ALL cyber incidents detection timeline including parent company and subsidiaries
ALL Company Subsidiaries
A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient, like a spark that could ignite a thousand more ideas. And it did! Looking back at our 4 decade, illustrious journey, that one small idea has Not only triggered us to become one of India’s largest generic and specialty pharmaceutical company but also, create a foothold in over 50 countries 32% of our revenue is generated via offshore sales. As well as we have consistently been ranked amongst the top ten pharmaceutical companies in India. Our portfolio includes illustrious brands like Clavam, Pan, Pan-D and Taxim-O, which feature amongst top 50 pharmaceutical brands in India. For over a decade, our dominance in anti-infective segment has remained unchallenged. We have 21 manufacturing facilities at multiple locations in India and the United States of America. Our upper-crest facilities are inspected and audited as per cGMP guidelines as laid down by leading regulatory authorities such as USFDA, MHRA - UK, SAHPRA-South Africa, TGA - Australia, ANVISA - Brazil, WHO - Geneva, TPD - Health Canada, PPB - Kenya, NDA - Uganda, MOH - Sudan, INVIMA - Colombia, TFDA - Tanzania, Zimbabwe, BfArM-Germany & Other Africa, Asian & CIS Countries. Another feather in our cap was added on December 23rd, 2015, when, Alkem completed it's Initial Public Offering (IPO) and was listed on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited. Although passion is the fuel that keeps ideas alive, innovation is the catalyst that gives it flight! With over 500 scientists working in 5 global R&D centers, we are empowering innovations that align with our philosophy of ‘Extended Lifecare Beyond Boundaries’.
Loading...
ALL Similar Companies
MSD
At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important
Zoetis
The world’s leading animal health company. We’ve been innovating ways to predict, prevent, detect, and treat animal illness for over 70 years, and we continue to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers. Our leading portfolio an
UCB
At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine
Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out mor
Sandoz
Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health c
EMS is the leading pharmaceutical company in Brazil. Established since 45 years and with 100% national capital, the company has two industrial plants strategically placed in São Bernardo do Campo and Hortolândia, in the state of São Paulo. With a work based on daring, simplicity, excellence and res
Lonza
Lonza is a pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing. United by a common purpose, we turn our customers’ breakthrough innovations into viable therapies and manufacture the medicines of tomorrow. Founded in Sw
At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating wit
Fresenius Kabi
As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portf
.png)
ALL CyberSecurity News
August 12, 2025 07:00 AM
Closing Bell: Sonata Software, Alkem Lab among top gainers as Nifty closes at 24,487; Sensex drops 368 points
Nifty 50 closed at 24487.40, down 97.60 points or 0.40%, Bank Nifty ended at 55043.70, falling 467.10 points or 0.84%, and Sensex settled at...
July 16, 2025 03:58 PM
Adroit Biomeds Shareholders divests 100% stake to Alkem Laboratories
EY successfully advised Adroit Biomed Limited on its 100% stake sale to Alkem Laboratories for a total consideration of INR 140 crore.
June 18, 2025 07:00 AM
Diwakar Gupta to join Alkem Labs as Independent Director
Maharashtra: Alkem Labs has announced the appointment of Diwakar Gupta as Additional Director designated as an Independent Director on the...
May 17, 2025 07:00 AM
Pharma Giant Hit by Cyber Fraud; Financial Loss Under Probe
A cybersecurity breach at a US subsidiary of Enzene Biosciences Ltd, a wholly-owned arm of Alkem Laboratories, has resulted in the fraudulent transfer of funds.
May 16, 2025 07:00 AM
Cybersecurity incident at Alkem Labs US arm, investigation underway
Alkem Labs has announced that its subsidiary Enzene Biosciences Limited has detected a cyber security incident on its US subsidiary.
May 16, 2025 07:00 AM
Alkem reports cyber security incident at Enzene’s US subsidiary
Drugmaker Alkem Laboratories has reported a cyber security incident at its subsidiary Enzene Biosciences. The incident resulted in a fraudulent transfer of...
May 15, 2025 07:00 AM
Alkem Labs US arm hit by cyber fraud; financial loss under probe
Pharmaceutical company Alkem Laboratories Ltd on Thursday (May 15) disclosed a cybersecurity breach at a US subsidiary of Enzene Biosciences Ltd.
May 15, 2025 07:00 AM
Alkem’s Enzene Biosciences Hit by Cyberattack, Funds Fraudulently Transferred
Alkem Laboratories Ltd has revealed that its wholly owned subsidiary, Enzene Biosciences, was the target of a cyberattack affecting its US operations.
February 08, 2025 08:00 AM
Rs 22 Crore Gone in a Click: Pharma Giant Alkem Labs Falls Victim to Cyber Fraud
Mumbai: Cyber fraud has sent shockwaves through the pharma sector as Alkem Laboratories, a Mumbai-based pharmaceutical company,...
Frequently Asked Questions
Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
ALL CyberSecurity History Information
Official Website of Alkem Laboratories Ltd.
The official website of Alkem Laboratories Ltd. is http://www.alkemlabs.com.
Alkem Laboratories Ltd.’s AI-Generated Cybersecurity Score
According to Rankiteo, Alkem Laboratories Ltd.’s AI-generated cybersecurity score is 776, reflecting their Fair security posture.
How many security badges does Alkem Laboratories Ltd.’ have ?
According to Rankiteo, Alkem Laboratories Ltd. currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
Does Alkem Laboratories Ltd. have SOC 2 Type 1 certification ?
According to Rankiteo, Alkem Laboratories Ltd. is not certified under SOC 2 Type 1.
Does Alkem Laboratories Ltd. have SOC 2 Type 2 certification ?
According to Rankiteo, Alkem Laboratories Ltd. does not hold a SOC 2 Type 2 certification.
Does Alkem Laboratories Ltd. comply with GDPR ?
According to Rankiteo, Alkem Laboratories Ltd. is not listed as GDPR compliant.
Does Alkem Laboratories Ltd. have PCI DSS certification ?
According to Rankiteo, Alkem Laboratories Ltd. does not currently maintain PCI DSS compliance.
Does Alkem Laboratories Ltd. comply with HIPAA ?
According to Rankiteo, Alkem Laboratories Ltd. is not compliant with HIPAA regulations.
Does Alkem Laboratories Ltd. have ISO 27001 certification ?
According to Rankiteo,Alkem Laboratories Ltd. is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Industry Classification of Alkem Laboratories Ltd.
Alkem Laboratories Ltd. operates primarily in the Pharmaceutical Manufacturing industry.
Number of Employees at Alkem Laboratories Ltd.
Alkem Laboratories Ltd. employs approximately 15,251 people worldwide.
Subsidiaries Owned by Alkem Laboratories Ltd.
Alkem Laboratories Ltd. presently has no subsidiaries across any sectors.
Alkem Laboratories Ltd.’s LinkedIn Followers
Alkem Laboratories Ltd.’s official LinkedIn profile has approximately 647,457 followers.
NAICS Classification of Alkem Laboratories Ltd.
Alkem Laboratories Ltd. is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.
Alkem Laboratories Ltd.’s Presence on Crunchbase
No, Alkem Laboratories Ltd. does not have a profile on Crunchbase.
Alkem Laboratories Ltd.’s Presence on LinkedIn
Yes, Alkem Laboratories Ltd. maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/alkem-laboratories-ltd.
Cybersecurity Incidents Involving Alkem Laboratories Ltd.
As of December 22, 2025, Rankiteo reports that Alkem Laboratories Ltd. has not experienced any cybersecurity incidents.
Number of Peer and Competitor Companies
Alkem Laboratories Ltd. has an estimated 5,459 peer or competitor companies worldwide.
Alkem Laboratories Ltd. CyberSecurity History Information
How many cyber incidents has Alkem Laboratories Ltd. faced ?
Total Incidents: According to Rankiteo, Alkem Laboratories Ltd. has faced 0 incidents in the past.
What types of cybersecurity incidents have occurred at Alkem Laboratories Ltd. ?
Incident Types: The types of cybersecurity incidents that have occurred include .
Incident Details
What are the most common types of attacks the company has faced ?
Additional Questions
.png)
Latest Global CVEs (Not Company-Specific)
Description
A vulnerability has been found in SeaCMS up to 13.3. The affected element is an unknown function of the file js/player/dmplayer/dmku/class/mysqli.class.php. Such manipulation of the argument page/limit leads to sql injection. The attack can be executed remotely. The exploit has been disclosed to the public and may be used.
Risk Information
cvss2
Base: 7.5
Severity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
cvss3
Base: 7.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in HappyDevs TempTool allows Stored XSS.This issue affects TempTool: from n/a through 1.3.1.
Risk Information
cvss3
Base: 6.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:L
Description
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Tormorten WP Microdata allows Stored XSS.This issue affects WP Microdata: from n/a through 1.0.
Risk Information
cvss3
Base: 6.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:L
Description
Exposure of Sensitive System Information to an Unauthorized Control Sphere vulnerability in HappyDevs TempTool allows Retrieve Embedded Sensitive Data.This issue affects TempTool: from n/a through 1.3.1.
Risk Information
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
Description
A vulnerability has been found in Tenda FH1201 1.2.0.14(408). Affected is the function sprintf of the file /goform/SetIpBind. Such manipulation of the argument page leads to stack-based buffer overflow. The attack may be performed from remote. The exploit has been disclosed to the public and may be used.
Risk Information
cvss2
Base: 9.0
Severity: LOW
AV:N/AC:L/Au:S/C:C/I:C/A:C
cvss3
Base: 8.8
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
cvss4
Base: 7.4
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
- https://github.com/z472421519/BinaryAudit/blob/main/PoC/BOF/Tenda_FH1201/SetIpBind/SetIpBind.md
- https://github.com/z472421519/BinaryAudit/blob/main/PoC/BOF/Tenda_FH1201/SetIpBind/SetIpBind.md#reproduce
- https://vuldb.com/?ctiid.337689
- https://vuldb.com/?id.337689
- https://vuldb.com/?submit.719154
- https://www.tenda.com.cn/
Access Data Using Our API
Get company history
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=alkem-laboratories-ltd' -H 'apikey: YOUR_API_KEY_HERE'
RapidWhat Do We Measure ?
Incident
Finding
Grade
Digital Assets
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
These are some of the factors we use to calculate the overall score:
Network Security
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
SBOM (Software Bill of Materials)
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
CMDB (Configuration Management Database)
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Threat Intelligence
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
